Access to Research and infrastructure: The Contract Research Industry


The Event

April 27-28, 2023  |  8:00 am – 5:00 pm (central time)

This event features industry leaders that provide a detailed exploration of the intricate contract research market.

Join the symposium to:


  • Ask direct questions of and connect with industry leaders
  • Understand the CRO market and growth opportunities
  • Explore the impact of CRO consolidation and customer concentration
  • Learn about new and emerging regulations that impact drug development
  • Meet CRO executives and learn about their company’s services and expertise
  • Identify tools and technologies that aid in advancing the CRO industry
  • And more!

Attendees also have the opportunity to visit contract research laboratories in Kansas City.

Registration Costs


Early Registration BioKansas Members – $150 (until February 28)

Early Registration Non-BioKansas Members  – $200 (until February 28)


Regular Registration BioKansas Members – $200

Regular Registration Non-BioKansas Members – $250


Onsite Registration – $290

Meet the Speakers

John Bucksath

Chief Executive Officer | Integris BioServices dba KCAS

Brandon Clough

Chief Revenue Officer | PSC Biotech and PSC Software

Andrea Bradley Ewing

Senior Director of Community Engaged Research | Children’s Mercy, Kansas City

Kyle Kappler

Senior Consultant of Discovery, Nonclinical, and Animal Health | Latham BioPharm Group

Amy Mize

Sr.Vice President Business Development | KCAS Bioanalytical and Biomarker Services

Dr. James Randazoo, PhD, DABT

Director of Toxicology | Attentive Science

Jonathan White

Director, Pharmaceutical Sciences | MRIGlobal

Phillip Beske, PhD, DABT

Director, Medical Research | MRIGlobal

Cartier Esham, PhD

Chief Scientific Officer | Biotechnology Innovation Organization

Michelle Fosler

Technical Sales Specialist - ADME Tox | XenoTech a BioIVT company

Christine Lee

Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner | U.S. Food and Drug Administration

Justin Mutzbauer

Executive Producer, Business Insurance Healthcare | Life Sciences Practice Marsh McLennan Agency

Crissa Cook

Patent Attorney | Hovey Williams

Mark Wissel, PhD

Director, R&D | Eurofins Viracor BioPharma Services

Dr. Mario Castro, MD, MPH

L. E. Phillips and Lenora Carr Phillips Professor Chief, Pulmonary, Critical Care and Sleep Medicine Vice Chair for Clinical and Translational Research Director, Frontiers Clinical and Translational Science Institute at the University of Kansas

Karina Eterovic

R&D Director for Oncology and Sequencing | Eurofins-Viracor

Robert Hunter

Chief Science and Regulatory Officer | Veterinary Health Research Centers

Matthew McClorey

President | CritiTech Particle Engineering Solutions

Stephanie Pasas-Farmer, PhD

President and Principal Consultant | BioData Solutions, LLC President and Founder | Ariadne Software, LLC

Greg Slaybaugh

Director, CQV | Arcadis DPS Group

Greg Slaybaugh

Director, CQV | Arcadis DPS Group

Event Moderators

Sonia Hall

President & CEO BioKansas

DJ Rezac

Senior Consultant Latham Biopharm Group



8:30-9:00 am


Location: Kansas State University – Olathe

22201 W Innovation Drive

Olathe, KS 66061

9:00-9:30 am


The CRO Investment Market: Keeping up with an ever evolving services business model serving the biotech and pharmaceutical industries

9:30 am

A Buyers Guide for Navigating the Current Contract Research Organization Landscape

10:00 am

Regulated PCR and Biologics Trial Support

10:15 am

Cybersecurity State of the Market

10:30 am

Maximizing IP Value: Tips and Best Practices for CROs in R&D Collaboration

10:45-11:15 am

Coffee & Collaboration

11:15 am – 12:00 pm

Panel Discussion

Advancing Business Objectives In A Changing Market

12:00-1:15 pm

Lunch & Networking

1:15 pm

Considerations for Formulation Development and Analysis in Preclinical Toxicology Studies


1:30 pm

Veterinary Health Research Centers, Real World Data

1:45 pm

Exploring the Application of NGS (Next Generation Sequencing) and Other Molecular Tools in Oncology Clinical Testing and Drug Development

2:00 pm

 Advancing drug development with high quality, science-first, client centric culture at KCAS

2:15 pm

CritiTech Particle Engineering Solutions – A Multiservice CDMO Providing POC to GMP Drug Development, Manufacturing and Analytical Services & Solving Formulation Challenges Through Particle Engineering

2:30 pm

CRO support for toxicology and medical countermeasure development

3:00-4:30 pm

Networking Reception


9:00 am

XenoTech, a BioIVT Company – An Overview of Services

9:15 am

Increasing Efficiencies and Impact: The Current State of AI in Pharmaceutical R&D

9:30 am

CRO Support for Clinical Trial Materials

9:45 am

cGMP and Annex I

10:00 am

Leveraging Innovative Software for Start-ups, MIdsized, and Large Companies

10:15-10:45 am

Coffee & Connections

10:30-11:00 am

Diversity In Clinical Trials

11:00-11:45 am

Diversity In Clinical Trials Panel Discussion

11:45 am – 12:45 pm


1:00-4:00 pm

Facility Tours

Event Sponsors


Listen, Share, & Advance Kansas